ARTICLE | Finance
Athira, Compass IPOs help quartet push biopharmas’ 2020 NASDAQ haul above $9B
September 19, 2020 12:00 AM UTC
Among a pair of companies that priced upsized IPOs ahead of Friday’s session, neurodegeneration play Athira gave back most of its early gains, while depression company Compass scored a double-digit bump.
The deals conclude a week in which two other biopharmas went public, with one gaining and the other ceding value. Dyne Therapeutics Inc. (NASDAQ:DYN) finished the week up 19% from its listing price, while Metacrine Inc. (NASDAQ:MTCR) shed 22%...